These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1034478)

  • 1. Inactivation of dihydrofolate reductase in vitro by binding to microsomal membranes.
    Fox JE; Hillcoat BL
    Biochem Biophys Res Commun; 1976 Dec; 73(3):562-8. PubMed ID: 1034478
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversibility of high-affinity binding of methotrexate in L1210 murine leukemia cells.
    Cohen M; Bender RA; Donehower R; Myers CE; Chabner BA
    Cancer Res; 1978 Sep; 38(9):2866-70. PubMed ID: 679194
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetic investigation of the reaction mechanism of dihydrofolate reductase from L1210 cells.
    McCullough JL; Nixon PF; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():131-42. PubMed ID: 4399849
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
    Jackson RC; Niethammer D; Hart LI
    Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
    [No Abstract]   [Full Text] [Related]  

  • 5. Ion-dependent activation of dihydrofolate reductase from L1210 cells.
    Reyes P; Huennekens FM
    Biochemistry; 1967 Nov; 6(11):3519-27. PubMed ID: 5235146
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
    Whitehead VM
    Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.
    Goldman ID; Lichtenstein NS; Oliverio VT
    J Biol Chem; 1968 Oct; 243(19):5007-17. PubMed ID: 5303004
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydrofolate reductase from the L1210 R murine lymphoma. Further studies on the binding of substrates and inhibitors to the enzyme.
    Hillcoat BL; Perkins JP; Bertino JR
    J Biol Chem; 1967 Oct; 242(20):4777-81. PubMed ID: 4383525
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
    Nahas A; Friedkin M
    Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of substrates and inhibitors to dihydrofolate reductase.
    Roberts GC
    Biochem Soc Trans; 1975; 3(5):630-1. PubMed ID: 261
    [No Abstract]   [Full Text] [Related]  

  • 13. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrofolate reductase: the current story.
    Gready JE
    Nature; 1979 Dec; 282(5740):674-5. PubMed ID: 514346
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.
    Sirotnak FM; DeGraw JI; Chello PL; Moccio DM; Dorick DM
    Cancer Treat Rep; 1982 Feb; 66(2):351-8. PubMed ID: 7055818
    [No Abstract]   [Full Text] [Related]  

  • 16. Sites of action of amethopterin: intrinsic and acquired drug resistance.
    Harrap KR; Hill BT; Furness ME; Hart LI
    Ann N Y Acad Sci; 1971 Nov; 186():312-24. PubMed ID: 5289423
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1972 Oct; 32(10):2120-6. PubMed ID: 4404161
    [No Abstract]   [Full Text] [Related]  

  • 18. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC; Fan CC; Howell SB
    J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic dihydrofolate reductase.
    Blakley RL
    Adv Enzymol Relat Areas Mol Biol; 1995; 70():23-102. PubMed ID: 8638484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.